These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 32546626)

  • 1. Expression of the Long Noncoding RNA DINO in Human Papillomavirus-Positive Cervical Cancer Cells Reactivates the Dormant TP53 Tumor Suppressor through ATM/CHK2 Signaling.
    Sharma S; Munger K
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells.
    Sharma S; Munger K
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
    Barr JA; Hayes KE; Brownmiller T; Harold AD; Jagannathan R; Lockman PR; Khan S; Martinez I
    Sci Rep; 2019 Mar; 9(1):3662. PubMed ID: 30842470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
    Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53.
    Hoppe-Seyler F; Butz K
    J Virol; 1993 Jun; 67(6):3111-7. PubMed ID: 8388491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes.
    Wei L; Griego AM; Chu M; Ozbun MA
    Carcinogenesis; 2014 Oct; 35(10):2373-81. PubMed ID: 25064354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
    Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
    J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes.
    Narisawa-Saito M; Handa K; Yugawa T; Ohno S; Fujita M; Kiyono T
    Oncogene; 2007 May; 26(21):2988-96. PubMed ID: 17146442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
    Au Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
    Berger KL; Barriga F; Lace MJ; Turek LP; Zamba GJ; Domann FE; Lee JH; Klingelhutz AJ
    Virology; 2006 Dec 5-20; 356(1-2):68-78. PubMed ID: 16945398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus 16 (HPV-16), HPV-18, and HPV-31 E6 Override the Normal Phosphoregulation of E6AP Enzymatic Activity.
    Thatte J; Banks L
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.